Gsk (GSK) Cash & Equivalents (2009 - 2026)
Gsk (GSK) posted Cash & Equivalents of $4.5 billion for Q4 2025, down 9.03% on a QoQ basis from $5.0 billion in Q4 2024, and down 9.03% year-over-year from $5.0 billion in Q4 2024.
Gsk (GSK) has 11 years of Cash & Equivalents data on file, last reported at $4.5 billion in Q4 2025.
- In Q4 2025, Cash & Equivalents fell 9.03% year-over-year to $4.5 billion; the TTM figure through Dec 2025 stood at $4.5 billion (down 9.03% YoY), while the FY2025 annual figure was $4.5 billion, down 9.03% from the prior year.
- Cash & Equivalents declined to $4.5 billion in Q4 2025, from $5.0 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $5.8 billion in Q4 2021 and bottomed at $3.6 billion in Q4 2023.
- A 5-year average of $4.7 billion and a median of $4.5 billion in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2021 — Cash & Equivalents sank 30.65% — and 2024, when it surged 36.31%.
- Year by year, Cash & Equivalents stood at $5.8 billion in 2021, then retreated by 24.21% to $4.4 billion in 2022, then declined by 16.55% to $3.6 billion in 2023, then surged by 36.31% to $5.0 billion in 2024, then fell by 9.03% to $4.5 billion in 2025.
- The last three Cash & Equivalents figures came in at $4.5 billion (Q4 2025), $5.0 billion (Q4 2024), and $3.6 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 21.69 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.33 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.63 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 1.70 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 9.57 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.64 Bn |
| Dec 31, 2025 | 4.52 Bn |
| Sep 30, 2025 | 4.45 Bn |
| Jun 30, 2025 | 4.80 Bn |
| Mar 31, 2025 | 5.62 Bn |
| Dec 31, 2024 | 4.97 Bn |
| Sep 30, 2024 | 4.15 Bn |
| Jun 30, 2024 | 3.74 Bn |
| Mar 31, 2024 | 3.54 Bn |
| Dec 31, 2023 | 3.64 Bn |
| Sep 30, 2023 | 4.02 Bn |
| Jun 30, 2023 | 3.93 Bn |
| Mar 31, 2023 | 3.51 Bn |
| Dec 31, 2022 | 4.37 Bn |
| Sep 30, 2022 | 4.25 Bn |
| Jun 30, 2022 | 8.14 Bn |
| Mar 31, 2022 | 14.72 Bn |
| Dec 31, 2021 | 5.76 Bn |
| Sep 30, 2021 | 4.76 Bn |
| Jun 30, 2021 | 4.90 Bn |
| Mar 31, 2021 | 6.56 Bn |
| Dec 31, 2020 | 8.31 Bn |
| Sep 28, 2020 | 10.34 Bn |
| Jun 30, 2020 | 10.14 Bn |
| Mar 31, 2020 | 6.11 Bn |
| Dec 31, 2019 | 6.05 Bn |
| Sep 30, 2019 | 5.31 Bn |
| Jun 30, 2019 | 5.30 Bn |
| Mar 31, 2019 | 5.38 Bn |
| Dec 31, 2018 | 4.98 Bn |
| Sep 30, 2018 | 4.94 Bn |
| Jun 30, 2018 | 5.51 Bn |
| Mar 31, 2018 | 5.57 Bn |
| Dec 31, 2017 | 5.09 Bn |
| Sep 30, 2017 | 6.21 Bn |
| Jun 30, 2017 | 5.09 Bn |
| Mar 31, 2017 | 5.59 Bn |
| Dec 31, 2016 | 6.09 Bn |
| Sep 30, 2016 | 6.07 Bn |
| Jun 30, 2016 | 6.59 Bn |
| Mar 31, 2016 | 7.42 Bn |
| Dec 31, 2015 | 8.85 Bn |
| Sep 30, 2015 | 10.97 Bn |
| Jun 30, 2015 | 12.13 Bn |
| Mar 31, 2015 | 15.61 Bn |
| Dec 31, 2014 | 6.87 Bn |
| Sep 30, 2014 | 6.86 Bn |
| Jun 30, 2014 | 5.32 Bn |
| Mar 31, 2014 | 5.81 Bn |
| Dec 31, 2013 | 8.96 Bn |
| Sep 30, 2013 | 5.04 Bn |
| Jun 30, 2013 | 4.36 Bn |
| Mar 31, 2013 | 5.96 Bn |
| Dec 31, 2012 | 6,423.48 Bn |
| Sep 30, 2012 | 5.35 Bn |
| Jun 30, 2012 | 11.70 Bn |
| Mar 31, 2012 | 8.85 Bn |
| Dec 31, 2011 | 12,572.54 Bn |
| Sep 30, 2011 | 8.72 Bn |
| Jun 30, 2011 | 9.53 Bn |
| Mar 31, 2011 | 10.41 Bn |
| Dec 31, 2010 | 9.57 Bn |
| Sep 30, 2010 | 9.66 Bn |
| Jun 30, 2010 | 9.81 Bn |
| Mar 31, 2010 | 10.87 Bn |
| Dec 31, 2009 | 10.69 Bn |
| Sep 30, 2009 | 10.61 Bn |
| Jun 30, 2009 | 8.28 Bn |
| Mar 31, 2009 | 8.94 Bn |